348 related articles for article (PubMed ID: 28172715)
21. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
Black-Maier E; Kim S; Steinberg BA; Fonarow GC; Freeman JV; Kowey PR; Ansell J; Gersh BJ; Mahaffey KW; Naccarelli G; Hylek EM; Go AS; Peterson ED; Piccini JP;
Clin Cardiol; 2017 Sep; 40(9):746-751. PubMed ID: 28543401
[TBL] [Abstract][Full Text] [Related]
22. Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation.
Imberti JF; Bonini N; Tosetti A; Mei DA; Gerra L; Malavasi VL; Mazza A; Lip GYH; Boriani G
Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336817
[TBL] [Abstract][Full Text] [Related]
23. [Tactics of anticoagulant therapy in patients with cardiac implantable electronic devices and subclinical atrial fibrillation: A review].
Razina TV; Serova MV; Andreev DA; Sazonova YS; Komarova AG
Ter Arkh; 2023 May; 95(4):472054. PubMed ID: 38158984
[TBL] [Abstract][Full Text] [Related]
24. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
[TBL] [Abstract][Full Text] [Related]
25. Atrial high-rate episodes: a comprehensive review.
Simu G; Rosu R; Cismaru G; Puiu M; Gusetu G; Minciuna I; Istratoaie S; Tomoaia R; Zdrenghea D; Pop D
Cardiovasc J Afr; 2021 Mar-Apr 23; 32(2):102-107. PubMed ID: 33496721
[TBL] [Abstract][Full Text] [Related]
26. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
Heart Rhythm; 2015 Dec; 12(12):2368-75. PubMed ID: 26164377
[TBL] [Abstract][Full Text] [Related]
27. Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.
Palomäki A; Mustonen P; Hartikainen JE; Nuotio I; Kiviniemi T; Ylitalo A; Hartikainen P; Airaksinen KE
Eur J Neurol; 2016 Jan; 23(1):133-9. PubMed ID: 26263442
[TBL] [Abstract][Full Text] [Related]
28. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
[TBL] [Abstract][Full Text] [Related]
29. Device-detected atrial fibrillation: what to do with asymptomatic patients?
Chen-Scarabelli C; Scarabelli TM; Ellenbogen KA; Halperin JL
J Am Coll Cardiol; 2015 Jan; 65(3):281-94. PubMed ID: 25614426
[TBL] [Abstract][Full Text] [Related]
30. Use of Anticoagulation for Thromboembolic Prophylaxis in Patients With Atrial High-Rate Episodes on Device Monitoring: A Narrative Review.
Leung ANW; Bhat A
Am J Cardiol; 2024 Jan; 211():183-190. PubMed ID: 37944778
[TBL] [Abstract][Full Text] [Related]
31. Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis.
Vitolo M; Imberti JF; Maisano A; Albini A; Bonini N; Valenti AC; Malavasi VL; Proietti M; Healey JS; Lip GY; Boriani G
Eur J Intern Med; 2021 Oct; 92():100-106. PubMed ID: 34154879
[TBL] [Abstract][Full Text] [Related]
32. Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated With Future Heart Failure Events - Clinical Significance of Asymptomatic Atrial Fibrillation in Patients With Implantable Cardiac Electronic Devices.
Nishinarita R; Niwano S; Fukaya H; Oikawa J; Nabeta T; Matsuura G; Arakawa Y; Kobayashi S; Shirakawa Y; Horiguchi A; Nakamura H; Ishizue N; Kishihara J; Satoh A; Ako J
Circ J; 2019 Mar; 83(4):736-742. PubMed ID: 30814400
[TBL] [Abstract][Full Text] [Related]
33. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
34. Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
Healey JS; Wong J
Europace; 2019 Mar; 21(3):377-382. PubMed ID: 30418608
[TBL] [Abstract][Full Text] [Related]
35. Stroke risk in patients with device-detected atrial high-rate episodes.
Erküner Ö; Rienstra M; Van Gelder IC; Schotten U; Crijns HJGM; Luermans JGLM
Neth Heart J; 2018 Apr; 26(4):177-181. PubMed ID: 29058207
[TBL] [Abstract][Full Text] [Related]
36. Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole.
Hindricks G; Theuns DA; Bar-Lev D; Anguera I; Ayala Paredes FA; Arnold M; Geller JC; Merkely B; Dyrda KM; Perings C; Maglia G; Ploux S; Meyhöfer J; Blomström-Lundqvist C; Karjalainen P; Liang Y; Diemberger I; Wranicz JK; Barr C; Quartieri F; Timmel T; Bollmann A
Europace; 2023 May; 25(5):. PubMed ID: 37038759
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
38. Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.
AlTurki A; Marafi M; Russo V; Proietti R; Essebag V
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547078
[TBL] [Abstract][Full Text] [Related]
39. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
[TBL] [Abstract][Full Text] [Related]
40. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
